Hyderabad India – 15 September 2021: Bioserve Biotechnologies India Pvt. Ltd. (a 100% owned subsidiary of REPROCELL Inc) will sponsor a webinar series hosted by the Society of Fetal Medicine in September. The title of the webinar is “Genetic Testing in Fetal Medicine-Navigating the Maze”.
Under the PRENITA Brand, Bioserve Biotechnologies India Pvt Ltd offers a range of prenatal and post-natal screening tests that provide accurate results with actionable insights, helping clinicians to analyze and provide the best outcome for patients. PRENITA provides the most advanced Preimplantation Genetic Screening/Diagnosis (PGS/PGD), Non-Invasive Prenatal Screening Test (NIPT), Invasive Diagnostic testing, Carrier Screening, and Single Gene Panels.
The webinar will take place on Wednesday 22nd September 2021, from 8:00 PM onwards
Clinical Capabilities / 2 September 2021
15 September 2021
2 September 2021
18 August 2021
© 2021 REPROCELL Inc. All rights reserved.